FNY Investment Advisers’s Halozyme HALO Stock Holding History

FNY Investment Advisers’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,147	Closed	-$50K	–	724
2022 Q2	$50K	Buy	+1,147	New	+$49.6K	0.04%	228

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Investment Advisers's HALO Position: Q3 2022 in Review

FNY Investment Advisers sold out of Halozyme (HALO) in Q3 2022, closing a stake of 1,147 shares — an estimated $50K sold.

FNY Investment Advisers first reported a position in HALO in Q2 2022 and held it in 1 quarter. The position peaked at $50K in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

FNY Investment Advisers reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
FNY Investment Advisers sold 1,147 Halozyme shares in Q3 2022, an estimated $50K.
FNY Investment Advisers first reported a position in Halozyme in Q2 2022 and held it in 1 quarter.
FNY Investment Advisers's Halozyme position peaked at $50K in Q2 2022.
357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.